BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24614839)

  • 21. [New mutations in myeloproliferative neoplasms; 2014 update].
    Kirito K
    Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation.
    Kawashima I; Kumagai T; Suzuki M; Suzuki J; Koshiishi M; Nakajima K; Kirito K
    Ann Hematol; 2019 Sep; 98(9):2249-2250. PubMed ID: 31240470
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature.
    Wang L; Du F; Zhang HM; Wang HX
    Braz J Med Biol Res; 2015 Jul; 48(7):583-7. PubMed ID: 26017341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
    Cui Y; Li B; Gale RP; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
    J Hematol Oncol; 2014 Oct; 7():77. PubMed ID: 25316523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic neutrophilic leukemia in a child with a CSF3R T618I germ line mutation.
    Druhan LJ; McMahon DP; Steuerwald N; Price AE; Lance A; Gerber JM; Avalos BR
    Blood; 2016 Oct; 128(16):2097-2099. PubMed ID: 27581359
    [No Abstract]   [Full Text] [Related]  

  • 26. Genomics of chronic neutrophilic leukemia.
    Maxson JE; Tyner JW
    Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.
    Ammatuna E; Eefting M; van Lom K; Kavelaars FG; Valk PJ; Touw IP
    Ann Hematol; 2015 May; 94(5):879-80. PubMed ID: 25491280
    [No Abstract]   [Full Text] [Related]  

  • 28. Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.
    Cogswell PC; Morgan R; Dunn M; Neubauer A; Nelson P; Poland-Johnston NK; Sandberg AA; Liu E
    Blood; 1989 Dec; 74(8):2629-33. PubMed ID: 2684296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.
    Price A; Druhan LJ; Lance A; Clark G; Vestal CG; Zhang Q; Foureau D; Parsons J; Hamilton A; Steuerwald NM; Avalos BR
    Biochem Biophys Res Commun; 2020 Feb; 523(1):208-213. PubMed ID: 31848046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.
    Koren-Michowitz M; Shimoni A; Daraio F; Crasto F; Lorenzatti R; Volchek Y; Amariglio N; Gottardi E; Saglio G; Nagler A
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1852-5. PubMed ID: 26151304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.
    Maxson JE; Luty SB; MacManiman JD; Abel ML; Druker BJ; Tyner JW
    J Biol Chem; 2014 Feb; 289(9):5820-7. PubMed ID: 24403076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique.
    Martiat P; Michaux JL; Rodhain J
    Blood; 1991 Jul; 78(1):205-11. PubMed ID: 2070054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allo-SCT for  Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).
    Cahu X; Chevallier P; Clavert A; Suarez F; Michallet M; Vincent L; Vigouroux S; Blaise D; Mariette C; Bilger K; Robin M; Yakoub-Agha I; Peffault de Latour R; Mohty M
    Bone Marrow Transplant; 2014 Jun; 49(6):756-60. PubMed ID: 24614840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis: clinical features and course of M-bcr negative and M-bcr positive CML.
    Dobrovic A; Morley AA; Seshadri R; Januszewicz EH
    Leukemia; 1991 Mar; 5(3):187-90. PubMed ID: 2013977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
    Valiente A; Outeriño J; Martín Calderín F; Benítez J
    Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
    Meggendorfer M; Haferlach T; Alpermann T; Jeromin S; Haferlach C; Kern W; Schnittger S
    Haematologica; 2014 Dec; 99(12):e244-6. PubMed ID: 25239264
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
    Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DNA analysis in chronic myelogenous leukemia, especially in clinical application of bcr gene rearrangement].
    Funato T; Bando Y; Ichikawa K; Ohtani H; Tokuhiro H
    Rinsho Byori; 1989 Mar; 37(3):306-10. PubMed ID: 2746921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.